文献速递手外科与足踝外科关节外科

全关节置换与大多角骨切除加韧带重建术治疗拇指腕掌关节骨关节炎的5年结局比较

Total Arthroplasty Versus Trapeziectomy With Ligamentoplasty for Trapeziometacarpal Osteoarthritis: 5-year Outcomes.
PubMed 文献 · Clin Orthop Relat Res · 2025-02-07

前瞻性平行组研究纳入54例Eaton-Littler III或IV期拇指腕掌关节骨关节炎患者,分别接受全关节置换或大多角骨切除加韧带重建术。5年随访时全关节置换组疼痛VAS和DASH评分均优于对照组,捏力无临床重要差异,Kapandji对掌评分更高。

要点

  • 5年随访时全关节置换组VAS疼痛评分1.3±0.7,低于大多角骨切除加韧带重建组的3.0±0.9。
  • 全关节置换组DASH评分11±9,低于对照组的28±12,上肢功能障碍更轻。
  • 两组捏力差异未达临床重要差异,Kapandji对掌评分全关节置换组更高。

核心结论

  • 作者认为,对于晚期拇指腕掌关节骨关节炎患者,尤其是疼痛明显和持续功能受限者,外科医生应考虑将全关节置换作为一线治疗选择。
  • 两种治疗均有益处,但全关节置换在疼痛缓解和功能残疾改善方面更优。
  • 未来研究应关注全关节置换与大多角骨切除加韧带重建术相比的长期耐久性,随访需超过10至20年以评估假体寿命和潜在晚期并发症。

研究设计与样本

  • 前瞻性平行组研究,在一家位于城市的三级转诊医院内专科手外科单元进行,54例患者按行政分配至两名不同外科医生。
  • 2018年2月至2018年6月治疗54例拇指腕掌关节骨关节炎患者,纳入标准为Eaton-Littler III或IV型、骨质量好、持续疼痛超过6个月、保守治疗无效。
  • 全关节置换组27例,大多角骨切除加韧带重建组27例;全关节置换组1例因个人原因失访被排除,最终全关节置换组26例、韧带重建组27例。
  • 全关节置换组26例中96%(25例)为女性,平均±SD年龄59±8岁;韧带重建组27例中96%(26例)为女性,平均±SD年龄59±7岁。
  • 所有患者平均±SD随访时间78±4个月;全关节置换组78±4个月,大多角骨切除加韧带重建组77±3个月;最低随访5年(60个月)。

主要发现

  • 5年时全关节置换组VAS疼痛评分1.3±0.7,低于大多角骨切除加韧带重建组的3.0±0.9,平均差异1.7(95%CI 1.3至2.1),p<0.001。
  • 5年时全关节置换组DASH评分11±9,低于大多角骨切除加韧带重建组的28±12,平均差异-17(95%CI -22至-12),p<0.001。
  • 5年时全关节置换组捏力3.7±0.6 kg,对照组3.2±0.6 kg,平均差异0.4(95%CI 0.1至0.8),p=0.01,但原文认为无临床重要差异。
  • 5年时全关节置换组Kapandji对掌评分9.9±0.4,高于大多角骨切除加韧带重建组的8.5±0.6,平均差异1.4(95%CI 1.0至1.8),p<0.001。

关键数值与推荐

  • 疼痛采用VAS评估,范围0(无痛)至10(最痛),临床显著变化定义为0.7至0.9。
  • 功能采用DASH问卷评估,最小临床重要差异(MCID)为10.83。
  • 捏力采用捏力计测量三次取平均值,MCID为0.33 kg。
  • 拇指对掌采用Kapandji指数评估,评分范围0至10。
  • 全关节置换组就诊时合并腕管综合征的比例为58%(26例中15例),高于大多角骨切除加韧带重建组的30%(27例中8例),p=0.04。

临床怎么用

  • 作者认为,外科医生应考虑将全关节置换作为晚期拇指腕掌关节关节炎患者的一线治疗选择,尤其是疼痛明显和持续功能受限者。
  • 作者指出两种治疗均有益处,但全关节置换在疼痛缓解和功能残疾改善方面更优。
  • 作者建议未来研究应关注全关节置换的长期耐久性,随访需超过10至20年以评估假体寿命和潜在晚期并发症。

局限性

  • 全关节置换组有1例患者因与研究和疾病无关的个人原因在干预后失访并被排除。
  • 全关节置换组有4%(1例)患者在5年前失访,韧带重建组0%(0例)在5年前失访。
  • 全关节置换组就诊时合并腕管综合征的比例高于对照组(58%[26例中15例] versus 30%[27例中8例];p=0.04)。
  • 作者指出全关节置换尚未证明优于大多角骨切除加韧带重建术,其耐久性仍存疑问。
  • 作者提出未来研究应关注全关节置换的长期耐久性,随访需超过10至20年以评估假体寿命和潜在晚期并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trapeziometacarpal (TMC) osteoarthritis is the most prevalent osteoarthritis of the upper limb. It is one of the most disabling conditions. Currently, the most suitable surgical technique is debated. Trapeziectomy with ligamentoplasty continues to be the gold standard; however, results for function, esthetics, and quality of life have not been optimal. For this reason, surgeons have continued to refine and develop various surgical techniques, among which total arthroplasty is increasingly emerging as a major alternative, but it has not yet demonstrated superiority and its durability is still in doubt. QUESTIONS/PURPOSES: At a minimum follow-up time of 5 years, do patients with total basilar thumb arthroplasty, compared with patients with trapeziectomy and ligament reconstruction, have (1) better pain as measured by a VAS scale, (2) lower disability as measured by the DASH, and (3) better tip pinch strength and functional range? METHODS: This was a prospective study conducted in a specialized hand surgery unit within a tertiary-level referral hospital located in an urban area, with 54 patients diagnosed with TMC osteoarthritis administratively assigned to two different surgeons. Between February 2018 and June 2018, we treated 54 patients for TMC osteoarthritis. Of those, we considered as potentially eligible patients who met the following inclusion criteria: TMC osteoarthritis classified as Eaton-Littler Type III or IV, good bone quality, persistent pain lasting for > 6 months, and failure to respond to conservative treatment. The study was designed as a parallel group study in which patients treated by one surgeon were treated with total arthroplasty and patients treated by the other study surgeon were treated with trapeziectomy with ligamentoplasty. Patients were administratively assigned to their groups, and the surgeons were comparably experienced and performed similar surgical volumes. A total of 27 patients were treated with total arthroplasty, and 27 patients were treated with trapeziectomy with ligamentoplasty. One patient in the total arthroplasty group was lost to follow-up after the intervention for personal reasons unrelated to the study or the disorder. For this reason, that patient was excluded from the study. Finally, among the 26 patients who underwent arthroplasty at the end of the follow-up period, 96% (25) were women, and the mean ± SD age was 59 ± 8 years. Four percent (1) of patients were lost to follow-up before 5 years. Of the 27 patients who received ligament reconstruction and tendon interposition, 96% (26) were women with a mean ± SD age of 59 ± 7 years. A total of 0% (0) were lost to follow-up before 5 years. This left 96% (26) of patients in the total arthroplasty group and 100% (27) in the tendon interposition arthroplasty group, respectively. The mean ± SD follow-up time for all patients was 78 ± 4 months. The mean follow-up time for patients who received total arthroplasty was 78 ± 4 months, and it was 77 ± 3 months for those who received trapeziectomy with ligamentoplasty. The minimum follow-up period for inclusion was 5 years (60 months). Patients in the two treatment groups did not differ in terms of age, sex, dominant hand surgery, functional work requirement, concomitant disorder, radiographic characteristics, and Eaton-Littler stage, but a higher percentage of patients in the total arthroplasty group had carpal tunnel syndrome at the time of presentation (58% [15 of 26] versus 30% [8 of 27]; p = 0.04). Pain was assessed using a VAS ranging from 0 (pain free) to 10 (maximum pain), with a clinically significant change defined as 0.7 to 0.9. Functionality was evaluated using the DASH questionnaire, with a minimum clinically important difference (MCID) of 10.83. Secondary outcomes included mobility, measured through radial abduction and retropulsion of the thumb using a goniometer, and thumb opposition assessed by the Kapandji index, which scores opposition on a scale of 0 to 10. Grip strength was measured with a pinch gauge, averaging three measurements, with an MCID of 0.33 kg. RESULTS: At 5 years, patients who had total arthroplasty had less pain compared to patients with trapeziectomy with ligament reconstruction (VAS 1.3 ± 0.7 versus 3.0 ± 0.9, mean difference 1.7 [95% confidence interval (CI) 1.3 to 2.1]; p < 0.001). Patients who had total arthroplasty had lower scores for upper extremity disability at 5 years (DASH 11 ± 9 versus 28 ± 12, mean difference -17 [95% CI -22 to -12]; p < 0.001). There was no clinically important difference between the groups in terms of tip pinch strength as measured in kg (3.7 ± 0.6 versus 3.2 ± 0.6, mean difference 0.4 [95% CI 0.1 to 0.8]; p = 0.01). Regarding mobility, we found differences between the total arthroplasty group and the trapeziectomy with ligamentoplasty group at 5 years of follow-up (Kapandji score 9.9 ± 0.4 versus 8.5 ± 0.6, mean difference 1.4 [95% CI 1.0 to 1.8]; p < 0.001). CONCLUSION: In light of these findings, surgeons should consider total arthroplasty as a first-line therapeutic option for patients with advanced TMC arthritis, especially those with significant pain and persistent functional limitations. While both treatments offer benefits, total arthroplasty provides superior pain relief and greater improvement in functional disability. Future studies should focus on the long-term durability of total arthroplasty compared to trapeziectomy with ligamentoplasty, with follow-up visits extending beyond 10 to 20 years to assess implant longevity and potential late complications.Level of Evidence Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Simón-Pérez C, Frutos-Reoyo EJ, Martín-Ferrero MÁ, et al. Total Arthroplasty Versus Trapeziectomy With Ligamentoplasty for Trapeziometacarpal Osteoarthritis: 5-year Outcomes. Clin Orthop Relat Res. 2025. PMID: 39982026. doi:10.1097/CORR.0000000000003404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。